\-\ Texto\\:\\ \ \(0\)\
\-\ no\\ masses\\,\\ discharge\\ or\\ skin\\ changes\\ by\\ physical\\ examination\\.\ \(0\)\
\-\ upfront\\ chemotherapy\\ followed\\ by\\ radiation\\ therapy\\ after\\ delivery\\ of\\ the\\ baby\\.\\ patient\\ considering\\ modified\\ radical\\ mastectomy\\ with\\ chemotherapy\\ and\\ hormonal\\ therapy\\ after\\ delivery\\ of\\ the\\ baby\\.\ \(0\)\
\-\ mammogram\\ \\‚\\Ä\\ì\\ 2\\ cm\\ of\\ architectural\\ distortion\\ present\\ in\\ the\\ right\\ upper\\ outer\\ quadrant\\.\\ us\\ was\\ negative\\.\ \(0\)\
\-\ infiltrating\\ ductal\\ carcinoma\ \(11\)\
\-\ malignancy\ \(256\)\
\-\ fibrocystic\\ changes\ \(2\)\
\-\ superimposition\ \(4\)\
\-\ surgical\\ scar\ \(10\)\
\-\ radial\\ sc\ \(3\)\
\-\ 39\\-year\\-old\\ female\\ presents\\ to\\ the\\ reproductive\\ endocrinology\\ clinic\\ for\\ ivf\\.\\ \\ a\\ screening\\ mammogram\\ is\\ performed\\,\\ but\\ not\\ interpreted\\ until\\ after\\ successful\\ ivf\\ is\\ performed\\.\\ \\ pt\\ now\\ at\\ 16\\ weeks\\ pregnancy\\.\ \(0\)\
\-\ breast\\ mass\\ descriptions\\ include\\ location\\,\\ size\\,\\ shape\\,\\ calcifications\\,\\ margins\\,\\ and\\ attenuation\\.\\ \\ location\\ is\\ typically\\ divided\\ into\\ quadrants\\.\\ \\ shape\\ descriptors\\ include\\ round\\,\\ oval\\,\\ lobulated\\,\\ irregular\\,\\ and\\ architectural\\ distortion\\.\\ \\ architectural\\ distortion\\ is\\ a\\ change\\ in\\ the\\ normal\\ breast\\ tissue\\ pattern\\.\\ \\ normal\\ anatomy\\ of\\ the\\ breast\\ involves\\ ducts\\ converging\\ at\\ the\\ nipple\\.\\ \\ distortion\\ is\\ seen\\ as\\ a\\ \\‚\\Ä\\úpulled\\ inward\\‚\\Ä\\ù\\ appearance\\ of\\ this\\ normal\\ architecture\\ in\\ one\\ focal\\ spot\\.\\ \\ \\ breast\\ cancer\\ is\\ the\\ most\\ common\\ cancer\\ in\\ pregnant\\ women\\.\\ \\ termination\\ of\\ pregnancy\\ has\\ not\\ been\\ shown\\ to\\ improve\\ maternal\\ outcomes\\,\\ but\\ is\\ an\\ option\\ in\\ patients\\ with\\ advanced\\ cancers\\ requiring\\ chemo\\ or\\ xrt\\.\\‚\\Ä\\¢rx\\ \\ stage\\ i\\ or\\ ii\\‚\\Ä\\ì\\ modified\\ radical\\ mastectomy\\ \\(as\\ opposed\\ to\\ lumpectomy\\ with\\ radiation\\,\\ which\\ is\\ considered\\ an\\ equivalent\\ rx\\)\\ to\\ avoid\\ radiation\\ exposure\\ to\\ the\\ fetus\\.\\ \\ if\\ adjuvant\\ chemo\\ necessary\\,\\ give\\ after\\ 1st\\ trimester\\.\\‚\\Ä\\¢rx\\ stage\\ iii\\ or\\ iv\\ \\‚\\Ä\\ì\\ surgery\\ with\\ chemo\\ after\\ 1st\\ trimester\\.\\ \\ \\‚\\Ä\\¢5\\ year\\ survival\\ for\\ these\\ patients\\ is\\ 10\\%\\ and\\ fetal\\ risk\\ is\\ incurred\\ during\\ 1st\\ trimester\\ rx\\,\\ therefore\\ therapeutic\\ abortion\\ should\\ be\\ considered\\,\\ although\\ it\\ will\\ not\\ improve\\ outcome\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ rx\\:\\ 0\\.29609984003405004\ \(0\)\
\-\ distortion\\:\\ 0\\.2463093396537965\ \(0\)\
\-\ chemo\\:\\ 0\\.21980510202097786\ \(0\)\
\-\ architectural\\:\\ 0\\.20329672422648076\ \(0\)\
\-\ trimester\\:\\ 0\\.19968926694660022\ \(0\)\
\-\ 1st\\:\\ 0\\.1820670214207681\ \(0\)\
\-\ breast\\:\\ 0\\.16916219261383947\ \(0\)\
\-\ is\\:\\ 0\\.15948797269106757\ \(0\)\
\-\ ivf\\:\\ 0\\.1465367346806519\ \(0\)\
\-\ after\\:\\ 0\\.14126038082574002\ \(0\)\
\-\ modified\\:\\ 0\\.13553114948432052\ \(0\)\
\-\ radical\\:\\ 0\\.12902875166884228\ \(0\)\
\-\ mastectomy\\:\\ 0\\.12362408493645945\ \(0\)\
\-\ radiation\\:\\ 0\\.11577946889544269\ \(0\)\
\-\ improve\\:\\ 0\\.11309896091864764\ \(0\)\
\-\ mammogram\\:\\ 0\\.11120448243730341\ \(0\)\
\-\ shape\\:\\ 0\\.11044345057481555\ \(0\)\
\-\ delivery\\:\\ 0\\.109470949732651\ \(0\)\
\-\ baby\\:\\ 0\\.10500984993087219\ \(0\)\
\-\ the\\:\\ 0\\.10458483126218979\ \(0\)\
\-\ pregnancy\\:\\ 0\\.09531781452884254\ \(0\)\
\-\ upfront\\:\\ 0\\.09313480422880514\ \(0\)\
\-\ descriptors\\:\\ 0\\.09313480422880514\ \(0\)\
\-\ stage\\:\\ 0\\.09275516919088991\ \(0\)\
\-\ considered\\:\\ 0\\.09076152267599723\ \(0\)\
\-\ incurred\\:\\ 0\\.08899527754787294\ \(0\)\
\-\ converging\\:\\ 0\\.08605823662690092\ \(0\)\
\-\ descriptions\\:\\ 0\\.08378009070047827\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.08270527839294271\ \(0\)\
\-\ superimposition\\:\\ 0\\.08191870994596871\ \(0\)\
\-\ inward\\:\\ 0\\.08191870994596871\ \(0\)\
\-\ location\\:\\ 0\\.08110540886840452\ \(0\)\
\-\ or\\:\\ 0\\.08103947319880841\ \(0\)\
\-\ pulled\\:\\ 0\\.0789816690249967\ \(0\)\
\-\ reproductive\\:\\ 0\\.0777791832650365\ \(0\)\
\-\ termination\\:\\ 0\\.0777791832650365\ \(0\)\
\-\ cancer\\:\\ 0\\.07758088831435332\ \(0\)\
\-\ sc\\:\\ 0\\.07573047011725759\ \(0\)\
\-\ fibrocystic\\:\\ 0\\.07402496000851251\ \(0\)\
\-\ to\\:\\ 0\\.07279658705383484\ \(0\)\
\-\ equivalent\\:\\ 0\\.07256399641764183\ \(0\)\
\-\ in\\:\\ 0\\.07243828240312278\ \(0\)\
\-\ hormonal\\:\\ 0\\.07190510142309248\ \(0\)\
\-\ endocrinology\\:\\ 0\\.07190510142309248\ \(0\)\
\-\ abortion\\:\\ 0\\.07190510142309248\ \(0\)\
\-\ normal\\:\\ 0\\.07133422058256822\ \(0\)\
\-\ changes\\:\\ 0\\.07039290760442223\ \(0\)\
\-\ architecture\\:\\ 0\\.06962695549666982\ \(0\)\
\-\ outcomes\\:\\ 0\\.06962695549666982\ \(0\)\
\-\ include\\:\\ 0\\.0693018349524889\ \(0\)\
\-\ give\\:\\ 0\\.06912884065939373\ \(0\)\
\-\ not\\:\\ 0\\.0689726081388949\ \(0\)\
\-\ performed\\:\\ 0\\.06890725923509737\ \(0\)\
\-\ quadrants\\:\\ 0\\.06865390251535336\ \(0\)\
\-\ of\\:\\ 0\\.0683811926772339\ \(0\)\
\-\ adjuvant\\:\\ 0\\.06776557474216026\ \(0\)\
\-\ lumpectomy\\:\\ 0\\.06734880957024715\ \(0\)\
\-\ therapy\\:\\ 0\\.0669227028296354\ \(0\)\
\-\ opposed\\:\\ 0\\.06619179973842172\ \(0\)\
\-\ patients\\:\\ 0\\.0655238131716581\ \(0\)\
\-\ divided\\:\\ 0\\.06482853382118825\ \(0\)\
\-\ interpreted\\:\\ 0\\.06451437583442114\ \(0\)\
\-\ maternal\\:\\ 0\\.06362604806122805\ \(0\)\
\-\ considering\\:\\ 0\\.0630740580119327\ \(0\)\
\-\ oval\\:\\ 0\\.06255038789476558\ \(0\)\
\-\ cancers\\:\\ 0\\.06255038789476558\ \(0\)\
\-\ outcome\\:\\ 0\\.062052273057489504\ \(0\)\
\-\ nipple\\:\\ 0\\.061577334913449126\ \(0\)\
\-\ pregnant\\:\\ 0\\.06112351224536559\ \(0\)\
\-\ fetus\\:\\ 0\\.060903948321029\ \(0\)\
\-\ avoid\\:\\ 0\\.06047849805375097\ \(0\)\
\-\ ducts\\:\\ 0\\.060070070431493386\ \(0\)\
\-\ therapeutic\\:\\ 0\\.05893453133100048\ \(0\)\
\-\ option\\:\\ 0\\.05875697330801891\ \(0\)\
\-\ requiring\\:\\ 0\\.058076099125247936\ \(0\)\
\-\ but\\:\\ 0\\.05759729423828375\ \(0\)\
\-\ infiltrating\\:\\ 0\\.05713302951052138\ \(0\)\
\-\ spot\\:\\ 0\\.05683708621009483\ \(0\)\
\-\ survival\\:\\ 0\\.05683708621009483\ \(0\)\
\-\ successful\\:\\ 0\\.05654948045932382\ \(0\)\
\-\ outer\\:\\ 0\\.055997490410028467\ \(0\)\
\-\ exposure\\:\\ 0\\.055346994699363626\ \(0\)\
\-\ anatomy\\:\\ 0\\.05522172528740778\ \(0\)\
\-\ scar\\:\\ 0\\.05497570545558528\ \(0\)\
\-\ advanced\\:\\ 0\\.0547354748663255\ \(0\)\
\-\ fetal\\:\\ 0\\.05404694464346136\ \(0\)\
\-\ lobulated\\:\\ 0\\.0537193444836058\ \(0\)\
\-\ women\\:\\ 0\\.05240995377839161\ \(0\)\
\-\ discharge\\:\\ 0\\.05222262138512224\ \(0\)\
\-\ therefore\\:\\ 0\\.05133429361192914\ \(0\)\
\-\ ductal\\:\\ 0\\.05124956840380578\ \(0\)\
\-\ involves\\:\\ 0\\.0506753986173798\ \(0\)\
\-\ iii\\:\\ 0\\.050284188725357705\ \(0\)\
\-\ radial\\:\\ 0\\.049981667955154144\ \(0\)\
\-\ margins\\:\\ 0\\.04968785403819257\ \(0\)\
\-\ by\\:\\ 0\\.04946223323563836\ \(0\)\
\-\ clinic\\:\\ 0\\.049056147685506486\ \(0\)\
\-\ necessary\\:\\ 0\\.048721385596921046\ \(0\)\
\-\ until\\:\\ 0\\.048461261232826465\ \(0\)\
\-\ and\\:\\ 0\\.04813645331971242\ \(0\)\
\-\ round\\:\\ 0\\.04771843704816404\ \(0\)\
\-\ screening\\:\\ 0\\.04730883883266023\ \(0\)\
\-\ as\\:\\ 0\\.04679232381359095\ \(0\)\
\-\ us\\:\\ 0\\.04632536284994251\ \(0\)\
\-\ with\\:\\ 0\\.04561470028237614\ \(0\)\
\-\ 16\\:\\ 0\\.045380761337998614\ \(0\)\
\-\ shown\\:\\ 0\\.04514605378321802\ \(0\)\
\-\ irregular\\:\\ 0\\.044962096932709035\ \(0\)\
\-\ attenuation\\:\\ 0\\.04455992694410479\ \(0\)\
\-\ an\\:\\ 0\\.04453982280753751\ \(0\)\
\-\ change\\:\\ 0\\.04413090041652719\ \(0\)\
\-\ at\\:\\ 0\\.043994253689093904\ \(0\)\
\-\ malignancy\\:\\ 0\\.04359883101547557\ \(0\)\
\-\ pattern\\:\\ 0\\.04347988603138941\ \(0\)\
\-\ skin\\:\\ 0\\.0433234181567508\ \(0\)\
\-\ calcifications\\:\\ 0\\.042503250200769366\ \(0\)\
\-\ pt\\:\\ 0\\.04191174376102729\ \(0\)\
\-\ iv\\:\\ 0\\.04161193768000765\ \(0\)\
\-\ risk\\:\\ 0\\.04161193768000765\ \(0\)\
\-\ typically\\:\\ 0\\.0408835216506421\ \(0\)\
\-\ quadrant\\:\\ 0\\.04079223047020371\ \(0\)\
\-\ now\\:\\ 0\\.03997737876563681\ \(0\)\
\-\ masses\\:\\ 0\\.03964712908772629\ \(0\)\
\-\ although\\:\\ 0\\.03964712908772629\ \(0\)\
\-\ size\\:\\ 0\\.03943275209854726\ \(0\)\
\-\ followed\\:\\ 0\\.03932722837889041\ \(0\)\
\-\ should\\:\\ 0\\.03800011335049815\ \(0\)\
\-\ will\\:\\ 0\\.03748335934220056\ \(0\)\
\-\ examination\\:\\ 0\\.03726659262204216\ \(0\)\
\-\ during\\:\\ 0\\.03688764618973583\ \(0\)\
\-\ negative\\:\\ 0\\.03605457878954178\ \(0\)\
\-\ year\\:\\ 0\\.03589544185801069\ \(0\)\
\-\ for\\:\\ 0\\.035302816334204117\ \(0\)\
\-\ appearance\\:\\ 0\\.03510926856710607\ \(0\)\
\-\ weeks\\:\\ 0\\.03490301248169803\ \(0\)\
\-\ carcinoma\\:\\ 0\\.034835176159123064\ \(0\)\
\-\ focal\\:\\ 0\\.034835176159123064\ \(0\)\
\-\ 10\\:\\ 0\\.03405446505546783\ \(0\)\
\-\ been\\:\\ 0\\.03392995950038158\ \(0\)\
\-\ if\\:\\ 0\\.03383756675229151\ \(0\)\
\-\ cm\\:\\ 0\\.03344658737900423\ \(0\)\
\-\ one\\:\\ 0\\.03334383266126835\ \(0\)\
\-\ common\\:\\ 0\\.03302746194144988\ \(0\)\
\-\ these\\:\\ 0\\.03288683535185017\ \(0\)\
\-\ physical\\:\\ 0\\.031577832605405025\ \(0\)\
\-\ surgery\\:\\ 0\\.03131106536442462\ \(0\)\
\-\ upper\\:\\ 0\\.031121339505199904\ \(0\)\
\-\ into\\:\\ 0\\.030958173240192902\ \(0\)\
\-\ tissue\\:\\ 0\\.0305501990434544\ \(0\)\
\-\ most\\:\\ 0\\.030308676771734135\ \(0\)\
\-\ present\\:\\ 0\\.029883669348604067\ \(0\)\
\-\ it\\:\\ 0\\.0298110785878316\ \(0\)\
\-\ surgical\\:\\ 0\\.02830543514890654\ \(0\)\
\-\ female\\:\\ 0\\.028102389488251018\ \(0\)\
\-\ presents\\:\\ 0\\.028015352908375472\ \(0\)\
\-\ seen\\:\\ 0\\.027417850439798042\ \(0\)\
\-\ has\\:\\ 0\\.026601296893023763\ \(0\)\
\-\ which\\:\\ 0\\.02648127400902785\ \(0\)\
\-\ be\\:\\ 0\\.023624717719093708\ \(0\)\
\-\ mass\\:\\ 0\\.022245257131981257\ \(0\)\
\-\ was\\:\\ 0\\.02029642451973146\ \(0\)\
\-\ this\\:\\ 0\\.02001153185135372\ \(0\)\
\-\ right\\:\\ 0\\.01930821621100924\ \(0\)\
\-\ patient\\:\\ 0\\.01894180906742893\ \(0\)\
\-\ no\\:\\ 0\\.018938246223565942\ \(0\)\
